BIOTECHNOLOGY VALUE FUND L P

Holdings History for 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Symbol: FDMT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 5,847,281 shares
Security Ownership %: 10%

BVF PARTNERS L P/IL ownership in 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT)

17 Feb 2026 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,847,281 shares of 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT). This represents 10% ownership of the company. In their previous filing dated 15 May 2025, BIOTECHNOLOGY VALUE FUND L P had reported owning 4,632,749 shares, indicating an increase of +26%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BVF PARTNERS L P/IL	10%	0%	$45,959,629	5,847,281	+1,214,532	+26%	$7.86	13G/A	31 Dec 2025	17 Feb 2026, 16:12
BVF PARTNERS L P/IL	10%	0%	$15,056,434	4,632,749	-201,548	-4.2%	$3.25	13G/A	31 Mar 2025	15 May 2025, 16:29
BVF PARTNERS L P/IL	10%		$15,711,465	4,834,297			$3.25	13G/A	31 Dec 2024	14 Feb 2025, 16:20